BioScience Health Innovations Files Q1 2025 10-Q
Ticker: BHIC · Form: 10-Q · Filed: May 8, 2025 · CIK: 1784440
| Field | Detail |
|---|---|
| Company | Bioscience Health Innovations, Inc. (BHIC) |
| Form Type | 10-Q |
| Filed Date | May 8, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, company-information
TL;DR
BioScience Health Innovations (formerly Nowtransit) filed its Q1 2025 10-Q. Based in NV.
AI Summary
BioScience Health Innovations, Inc. filed its quarterly report on Form 10-Q for the period ended March 31, 2025. The company, formerly known as Nowtransit Inc., is incorporated in Nevada and operates in the computer processing and data preparation sector. Its principal business address is in Salt Lake City, UT.
Why It Matters
This filing provides investors with an update on the company's financial performance and operational status for the first quarter of 2025.
Risk Assessment
Risk Level: low — This is a routine quarterly filing with no immediate red flags or significant new information presented in the provided text.
Key Numbers
- 333-234487 — SEC File Number (Identifies the company's filing with the SEC)
- 0001784440 — Central Index Key (Unique identifier for the company in the SEC EDGAR system)
Key Players & Entities
- BioScience Health Innovations, Inc. (company) — Registrant
- March 31, 2025 (date) — Quarterly period end date
- Nowtransit Inc. (company) — Former company name
- Nevada (jurisdiction) — State of incorporation
- Salt Lake City, UT (location) — Business address
FAQ
What is the primary business of BioScience Health Innovations, Inc.?
The company is classified under Standard Industrial Classification 7374, which is SERVICES-COMPUTER PROCESSING & DATA PREPARATION.
When was the company formerly known as?
The company was formerly known as Nowtransit Inc., with a date of name change on August 2, 2019.
Where is BioScience Health Innovations, Inc. located?
The company's business and mailing address is 2722 S West Temple, Salt Lake City, UT 84115.
What is the fiscal year end for BioScience Health Innovations, Inc.?
The company's fiscal year ends on December 31.
What type of report is this filing?
This is a Form 10-Q, a quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 8, 2025 regarding BioScience Health Innovations, Inc. (BHIC).